Opportunistic infections in patients with cancer
Open accessIntegrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Cancer patients frequently face an increased risk of secondary infections, a serious complication arising from both the disease and aggressive treatments such as chemotherapy, radiation, and surgery.
“Cancer patients frequently face an increased risk of secondary infections, a serious complication arising from both the disease and aggressive treatments such as chemotherapy, radiation, and surgery [122,123]”
From Phage therapy in oncology: opportunities for cancer prevention and treatment (2026) · cites this paper as [123]
These treatments weaken the immune system, leaving patients vulnerable to bacterial infections.
“These treatments weaken the immune system, leaving patients vulnerable to bacterial infections [122,123]”
From Phage therapy in oncology: opportunities for cancer prevention and treatment (2026) · cites this paper as [123]
Cited by
Sorted by citations
Distinct Responses of Human Monocyte Subsets to <i>Aspergillus fumigatus</i> Conidia
Serbina, N. V., Cherny, M., Shi, C., Bleau, S. A., Collins, N. H., Young, J. W., & Pamer, E. G. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803398 · Cited by 70 · see citing works
Gyetvai, Ã., Emri, T., Takács, K., Dergez, T., Fekete, A., Pesti, M., Pócsi, I., & Lenkey, B. (2006) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2006.00097.x · Cited by 53 · see citing works
Phage therapy in oncology: opportunities for cancer prevention and treatment
Mutalik, V. K., Inman, J. L., Chang, H., Arkin, A., & Mao, J.-H. (2026) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2026.02.001 · Cited by 5 · see citing works
- Authors
- Klastersky, J., & Aoun, M.
- Affiliations
- Université Libre de Bruxelles (BE)
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2004-10
- Volume
- 15
- Pages
- iv329-iv335
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W207096567
- Cited by
- 72
- References
- 0
- Citations by year
- 2026: 2 · 2025: 4 · 2023: 6 · 2022: 8 · 2021: 7 · 2020: 5 · 2019: 4 · 2018: 3 · 2017: 2 · 2016: 2 · 2015: 1 · 2014: 3 · 2013: 2 · 2012: 5
- FWCI
- 0.20
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Annals of Oncology (publishedVersion)
- PubMed (publishedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
- Keywords
- opportunistic infections, cancer patients, immunosuppression
- MeSH terms
- Candidiasis, Central Nervous System Infections, Humans, Neoplasms, Opportunistic Infections, Pneumonia, Fungemia, Bacteremia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
